Medical Care
Global CGT CDMO Market Research Report 2025
- Mar 24, 25
- ID: 136216
- Pages: 82
- Figures: 87
- Views: 42
The global market for CGT CDMO was valued at US$ 5665 million in the year 2024 and is projected to reach a revised size of US$ 25110 million by 2031, growing at a CAGR of 24.1% during the forecast period.
CGT CDMO is a contract service provider specializing in cell and gene therapy development and manufacturing. These organizations focus on supporting product development in the field of cell and gene therapies by pharmaceutical companies, biotechnology companies and research institutions.
Global key players of CGT CDMO include Catalent, Lonza and Thermo Fisher, etc. The top three players hold a share over 60%. North America is the largest market, has a share about 50%. In terms of product type, Immune Cells is the largest segment, occupied for a share of about 47%, and in terms of application, Pharmaceutical and Biotechnology Companies has a share about 82 percent.
This report aims to provide a comprehensive presentation of the global market for CGT CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CGT CDMO.
The CGT CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CGT CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CGT CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Lonza
Thermo Fisher
ACG Biologics
WuXi AppTec
Charles River
Oxford Biomedica (OXB)
Novartis
OBiO
GenScript
Pharmaron
Porton
Segment by Type
Immune Cells
Stem Cells
Viral Vectors
Plasmid DNA
Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CGT CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
CGT CDMO is a contract service provider specializing in cell and gene therapy development and manufacturing. These organizations focus on supporting product development in the field of cell and gene therapies by pharmaceutical companies, biotechnology companies and research institutions.
Global key players of CGT CDMO include Catalent, Lonza and Thermo Fisher, etc. The top three players hold a share over 60%. North America is the largest market, has a share about 50%. In terms of product type, Immune Cells is the largest segment, occupied for a share of about 47%, and in terms of application, Pharmaceutical and Biotechnology Companies has a share about 82 percent.
This report aims to provide a comprehensive presentation of the global market for CGT CDMO, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding CGT CDMO.
The CGT CDMO market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global CGT CDMO market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the CGT CDMO companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
Catalent
Lonza
Thermo Fisher
ACG Biologics
WuXi AppTec
Charles River
Oxford Biomedica (OXB)
Novartis
OBiO
GenScript
Pharmaron
Porton
Segment by Type
Immune Cells
Stem Cells
Viral Vectors
Plasmid DNA
Segment by Application
Pharmaceutical and Biotechnology Companies
Research and Academic Institutions
Hospital
Others
By Region
North America
United States
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Rest of Europe
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of CGT CDMO company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CGT CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immune Cells
1.2.3 Stem Cells
1.2.4 Viral Vectors
1.2.5 Plasmid DNA
1.3 Market by Application
1.3.1 Global CGT CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CGT CDMO Market Perspective (2020-2031)
2.2 Global CGT CDMO Growth Trends by Region
2.2.1 Global CGT CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CGT CDMO Historic Market Size by Region (2020-2025)
2.2.3 CGT CDMO Forecasted Market Size by Region (2026-2031)
2.3 CGT CDMO Market Dynamics
2.3.1 CGT CDMO Industry Trends
2.3.2 CGT CDMO Market Drivers
2.3.3 CGT CDMO Market Challenges
2.3.4 CGT CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CGT CDMO Players by Revenue
3.1.1 Global Top CGT CDMO Players by Revenue (2020-2025)
3.1.2 Global CGT CDMO Revenue Market Share by Players (2020-2025)
3.2 Global CGT CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CGT CDMO Revenue
3.4 Global CGT CDMO Market Concentration Ratio
3.4.1 Global CGT CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CGT CDMO Revenue in 2024
3.5 Global Key Players of CGT CDMO Head office and Area Served
3.6 Global Key Players of CGT CDMO, Product and Application
3.7 Global Key Players of CGT CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CGT CDMO Breakdown Data by Type
4.1 Global CGT CDMO Historic Market Size by Type (2020-2025)
4.2 Global CGT CDMO Forecasted Market Size by Type (2026-2031)
5 CGT CDMO Breakdown Data by Application
5.1 Global CGT CDMO Historic Market Size by Application (2020-2025)
5.2 Global CGT CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CGT CDMO Market Size (2020-2031)
6.2 North America CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CGT CDMO Market Size by Country (2020-2025)
6.4 North America CGT CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CGT CDMO Market Size (2020-2031)
7.2 Europe CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CGT CDMO Market Size by Country (2020-2025)
7.4 Europe CGT CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CGT CDMO Market Size (2020-2031)
8.2 Asia-Pacific CGT CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CGT CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific CGT CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CGT CDMO Market Size (2020-2031)
9.2 Latin America CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CGT CDMO Market Size by Country (2020-2025)
9.4 Latin America CGT CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CGT CDMO Market Size (2020-2031)
10.2 Middle East & Africa CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CGT CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa CGT CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent CGT CDMO Introduction
11.1.4 Catalent Revenue in CGT CDMO Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza CGT CDMO Introduction
11.2.4 Lonza Revenue in CGT CDMO Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher CGT CDMO Introduction
11.3.4 Thermo Fisher Revenue in CGT CDMO Business (2020-2025)
11.3.5 Thermo Fisher Recent Development
11.4 ACG Biologics
11.4.1 ACG Biologics Company Details
11.4.2 ACG Biologics Business Overview
11.4.3 ACG Biologics CGT CDMO Introduction
11.4.4 ACG Biologics Revenue in CGT CDMO Business (2020-2025)
11.4.5 ACG Biologics Recent Development
11.5 WuXi AppTec
11.5.1 WuXi AppTec Company Details
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec CGT CDMO Introduction
11.5.4 WuXi AppTec Revenue in CGT CDMO Business (2020-2025)
11.5.5 WuXi AppTec Recent Development
11.6 Charles River
11.6.1 Charles River Company Details
11.6.2 Charles River Business Overview
11.6.3 Charles River CGT CDMO Introduction
11.6.4 Charles River Revenue in CGT CDMO Business (2020-2025)
11.6.5 Charles River Recent Development
11.7 Oxford Biomedica (OXB)
11.7.1 Oxford Biomedica (OXB) Company Details
11.7.2 Oxford Biomedica (OXB) Business Overview
11.7.3 Oxford Biomedica (OXB) CGT CDMO Introduction
11.7.4 Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2020-2025)
11.7.5 Oxford Biomedica (OXB) Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis CGT CDMO Introduction
11.8.4 Novartis Revenue in CGT CDMO Business (2020-2025)
11.8.5 Novartis Recent Development
11.9 OBiO
11.9.1 OBiO Company Details
11.9.2 OBiO Business Overview
11.9.3 OBiO CGT CDMO Introduction
11.9.4 OBiO Revenue in CGT CDMO Business (2020-2025)
11.9.5 OBiO Recent Development
11.10 GenScript
11.10.1 GenScript Company Details
11.10.2 GenScript Business Overview
11.10.3 GenScript CGT CDMO Introduction
11.10.4 GenScript Revenue in CGT CDMO Business (2020-2025)
11.10.5 GenScript Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Details
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron CGT CDMO Introduction
11.11.4 Pharmaron Revenue in CGT CDMO Business (2020-2025)
11.11.5 Pharmaron Recent Development
11.12 Porton
11.12.1 Porton Company Details
11.12.2 Porton Business Overview
11.12.3 Porton CGT CDMO Introduction
11.12.4 Porton Revenue in CGT CDMO Business (2020-2025)
11.12.5 Porton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global CGT CDMO Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Immune Cells
1.2.3 Stem Cells
1.2.4 Viral Vectors
1.2.5 Plasmid DNA
1.3 Market by Application
1.3.1 Global CGT CDMO Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Pharmaceutical and Biotechnology Companies
1.3.3 Research and Academic Institutions
1.3.4 Hospital
1.3.5 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global CGT CDMO Market Perspective (2020-2031)
2.2 Global CGT CDMO Growth Trends by Region
2.2.1 Global CGT CDMO Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 CGT CDMO Historic Market Size by Region (2020-2025)
2.2.3 CGT CDMO Forecasted Market Size by Region (2026-2031)
2.3 CGT CDMO Market Dynamics
2.3.1 CGT CDMO Industry Trends
2.3.2 CGT CDMO Market Drivers
2.3.3 CGT CDMO Market Challenges
2.3.4 CGT CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top CGT CDMO Players by Revenue
3.1.1 Global Top CGT CDMO Players by Revenue (2020-2025)
3.1.2 Global CGT CDMO Revenue Market Share by Players (2020-2025)
3.2 Global CGT CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by CGT CDMO Revenue
3.4 Global CGT CDMO Market Concentration Ratio
3.4.1 Global CGT CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by CGT CDMO Revenue in 2024
3.5 Global Key Players of CGT CDMO Head office and Area Served
3.6 Global Key Players of CGT CDMO, Product and Application
3.7 Global Key Players of CGT CDMO, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 CGT CDMO Breakdown Data by Type
4.1 Global CGT CDMO Historic Market Size by Type (2020-2025)
4.2 Global CGT CDMO Forecasted Market Size by Type (2026-2031)
5 CGT CDMO Breakdown Data by Application
5.1 Global CGT CDMO Historic Market Size by Application (2020-2025)
5.2 Global CGT CDMO Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America CGT CDMO Market Size (2020-2031)
6.2 North America CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America CGT CDMO Market Size by Country (2020-2025)
6.4 North America CGT CDMO Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe CGT CDMO Market Size (2020-2031)
7.2 Europe CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe CGT CDMO Market Size by Country (2020-2025)
7.4 Europe CGT CDMO Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific CGT CDMO Market Size (2020-2031)
8.2 Asia-Pacific CGT CDMO Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific CGT CDMO Market Size by Region (2020-2025)
8.4 Asia-Pacific CGT CDMO Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America CGT CDMO Market Size (2020-2031)
9.2 Latin America CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America CGT CDMO Market Size by Country (2020-2025)
9.4 Latin America CGT CDMO Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa CGT CDMO Market Size (2020-2031)
10.2 Middle East & Africa CGT CDMO Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa CGT CDMO Market Size by Country (2020-2025)
10.4 Middle East & Africa CGT CDMO Market Size by Country (2026-2031)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Catalent
11.1.1 Catalent Company Details
11.1.2 Catalent Business Overview
11.1.3 Catalent CGT CDMO Introduction
11.1.4 Catalent Revenue in CGT CDMO Business (2020-2025)
11.1.5 Catalent Recent Development
11.2 Lonza
11.2.1 Lonza Company Details
11.2.2 Lonza Business Overview
11.2.3 Lonza CGT CDMO Introduction
11.2.4 Lonza Revenue in CGT CDMO Business (2020-2025)
11.2.5 Lonza Recent Development
11.3 Thermo Fisher
11.3.1 Thermo Fisher Company Details
11.3.2 Thermo Fisher Business Overview
11.3.3 Thermo Fisher CGT CDMO Introduction
11.3.4 Thermo Fisher Revenue in CGT CDMO Business (2020-2025)
11.3.5 Thermo Fisher Recent Development
11.4 ACG Biologics
11.4.1 ACG Biologics Company Details
11.4.2 ACG Biologics Business Overview
11.4.3 ACG Biologics CGT CDMO Introduction
11.4.4 ACG Biologics Revenue in CGT CDMO Business (2020-2025)
11.4.5 ACG Biologics Recent Development
11.5 WuXi AppTec
11.5.1 WuXi AppTec Company Details
11.5.2 WuXi AppTec Business Overview
11.5.3 WuXi AppTec CGT CDMO Introduction
11.5.4 WuXi AppTec Revenue in CGT CDMO Business (2020-2025)
11.5.5 WuXi AppTec Recent Development
11.6 Charles River
11.6.1 Charles River Company Details
11.6.2 Charles River Business Overview
11.6.3 Charles River CGT CDMO Introduction
11.6.4 Charles River Revenue in CGT CDMO Business (2020-2025)
11.6.5 Charles River Recent Development
11.7 Oxford Biomedica (OXB)
11.7.1 Oxford Biomedica (OXB) Company Details
11.7.2 Oxford Biomedica (OXB) Business Overview
11.7.3 Oxford Biomedica (OXB) CGT CDMO Introduction
11.7.4 Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2020-2025)
11.7.5 Oxford Biomedica (OXB) Recent Development
11.8 Novartis
11.8.1 Novartis Company Details
11.8.2 Novartis Business Overview
11.8.3 Novartis CGT CDMO Introduction
11.8.4 Novartis Revenue in CGT CDMO Business (2020-2025)
11.8.5 Novartis Recent Development
11.9 OBiO
11.9.1 OBiO Company Details
11.9.2 OBiO Business Overview
11.9.3 OBiO CGT CDMO Introduction
11.9.4 OBiO Revenue in CGT CDMO Business (2020-2025)
11.9.5 OBiO Recent Development
11.10 GenScript
11.10.1 GenScript Company Details
11.10.2 GenScript Business Overview
11.10.3 GenScript CGT CDMO Introduction
11.10.4 GenScript Revenue in CGT CDMO Business (2020-2025)
11.10.5 GenScript Recent Development
11.11 Pharmaron
11.11.1 Pharmaron Company Details
11.11.2 Pharmaron Business Overview
11.11.3 Pharmaron CGT CDMO Introduction
11.11.4 Pharmaron Revenue in CGT CDMO Business (2020-2025)
11.11.5 Pharmaron Recent Development
11.12 Porton
11.12.1 Porton Company Details
11.12.2 Porton Business Overview
11.12.3 Porton CGT CDMO Introduction
11.12.4 Porton Revenue in CGT CDMO Business (2020-2025)
11.12.5 Porton Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global CGT CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immune Cells
Table 3. Key Players of Stem Cells
Table 4. Key Players of Viral Vectors
Table 5. Key Players of Plasmid DNA
Table 6. Global CGT CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global CGT CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global CGT CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global CGT CDMO Market Share by Region (2020-2025)
Table 10. Global CGT CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global CGT CDMO Market Share by Region (2026-2031)
Table 12. CGT CDMO Market Trends
Table 13. CGT CDMO Market Drivers
Table 14. CGT CDMO Market Challenges
Table 15. CGT CDMO Market Restraints
Table 16. Global CGT CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global CGT CDMO Market Share by Players (2020-2025)
Table 18. Global Top CGT CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT CDMO as of 2024)
Table 19. Ranking of Global Top CGT CDMO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by CGT CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of CGT CDMO, Headquarters and Area Served
Table 22. Global Key Players of CGT CDMO, Product and Application
Table 23. Global Key Players of CGT CDMO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CGT CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global CGT CDMO Revenue Market Share by Type (2020-2025)
Table 27. Global CGT CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global CGT CDMO Revenue Market Share by Type (2026-2031)
Table 29. Global CGT CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global CGT CDMO Revenue Market Share by Application (2020-2025)
Table 31. Global CGT CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global CGT CDMO Revenue Market Share by Application (2026-2031)
Table 33. North America CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific CGT CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific CGT CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific CGT CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Catalent Company Details
Table 49. Catalent Business Overview
Table 50. Catalent CGT CDMO Product
Table 51. Catalent Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 52. Catalent Recent Development
Table 53. Lonza Company Details
Table 54. Lonza Business Overview
Table 55. Lonza CGT CDMO Product
Table 56. Lonza Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 57. Lonza Recent Development
Table 58. Thermo Fisher Company Details
Table 59. Thermo Fisher Business Overview
Table 60. Thermo Fisher CGT CDMO Product
Table 61. Thermo Fisher Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 62. Thermo Fisher Recent Development
Table 63. ACG Biologics Company Details
Table 64. ACG Biologics Business Overview
Table 65. ACG Biologics CGT CDMO Product
Table 66. ACG Biologics Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 67. ACG Biologics Recent Development
Table 68. WuXi AppTec Company Details
Table 69. WuXi AppTec Business Overview
Table 70. WuXi AppTec CGT CDMO Product
Table 71. WuXi AppTec Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 72. WuXi AppTec Recent Development
Table 73. Charles River Company Details
Table 74. Charles River Business Overview
Table 75. Charles River CGT CDMO Product
Table 76. Charles River Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 77. Charles River Recent Development
Table 78. Oxford Biomedica (OXB) Company Details
Table 79. Oxford Biomedica (OXB) Business Overview
Table 80. Oxford Biomedica (OXB) CGT CDMO Product
Table 81. Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 82. Oxford Biomedica (OXB) Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis CGT CDMO Product
Table 86. Novartis Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. OBiO Company Details
Table 89. OBiO Business Overview
Table 90. OBiO CGT CDMO Product
Table 91. OBiO Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 92. OBiO Recent Development
Table 93. GenScript Company Details
Table 94. GenScript Business Overview
Table 95. GenScript CGT CDMO Product
Table 96. GenScript Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 97. GenScript Recent Development
Table 98. Pharmaron Company Details
Table 99. Pharmaron Business Overview
Table 100. Pharmaron CGT CDMO Product
Table 101. Pharmaron Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 102. Pharmaron Recent Development
Table 103. Porton Company Details
Table 104. Porton Business Overview
Table 105. Porton CGT CDMO Product
Table 106. Porton Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 107. Porton Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. CGT CDMO Picture
Figure 2. Global CGT CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CGT CDMO Market Share by Type: 2024 VS 2031
Figure 4. Immune Cells Features
Figure 5. Stem Cells Features
Figure 6. Viral Vectors Features
Figure 7. Plasmid DNA Features
Figure 8. Global CGT CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global CGT CDMO Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical and Biotechnology Companies Case Studies
Figure 11. Research and Academic Institutions Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. CGT CDMO Report Years Considered
Figure 15. Global CGT CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CGT CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CGT CDMO Market Share by Region: 2024 VS 2031
Figure 18. Global CGT CDMO Market Share by Players in 2024
Figure 19. Global Top CGT CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT CDMO as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CGT CDMO Revenue in 2024
Figure 21. North America CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CGT CDMO Market Share by Country (2020-2031)
Figure 23. United States CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CGT CDMO Market Share by Country (2020-2031)
Figure 27. Germany CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CGT CDMO Market Share by Region (2020-2031)
Figure 35. China CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CGT CDMO Market Share by Country (2020-2031)
Figure 43. Mexico CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CGT CDMO Market Share by Country (2020-2031)
Figure 47. Turkey CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Catalent Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 51. Lonza Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 52. Thermo Fisher Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 53. ACG Biologics Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 54. WuXi AppTec Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 55. Charles River Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 56. Oxford Biomedica (OXB) Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 57. Novartis Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 58. OBiO Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 59. GenScript Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 60. Pharmaron Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 61. Porton Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Table 1. Global CGT CDMO Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Immune Cells
Table 3. Key Players of Stem Cells
Table 4. Key Players of Viral Vectors
Table 5. Key Players of Plasmid DNA
Table 6. Global CGT CDMO Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global CGT CDMO Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global CGT CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 9. Global CGT CDMO Market Share by Region (2020-2025)
Table 10. Global CGT CDMO Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 11. Global CGT CDMO Market Share by Region (2026-2031)
Table 12. CGT CDMO Market Trends
Table 13. CGT CDMO Market Drivers
Table 14. CGT CDMO Market Challenges
Table 15. CGT CDMO Market Restraints
Table 16. Global CGT CDMO Revenue by Players (2020-2025) & (US$ Million)
Table 17. Global CGT CDMO Market Share by Players (2020-2025)
Table 18. Global Top CGT CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT CDMO as of 2024)
Table 19. Ranking of Global Top CGT CDMO Companies by Revenue (US$ Million) in 2024
Table 20. Global 5 Largest Players Market Share by CGT CDMO Revenue (CR5 and HHI) & (2020-2025)
Table 21. Global Key Players of CGT CDMO, Headquarters and Area Served
Table 22. Global Key Players of CGT CDMO, Product and Application
Table 23. Global Key Players of CGT CDMO, Date of Enter into This Industry
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global CGT CDMO Market Size by Type (2020-2025) & (US$ Million)
Table 26. Global CGT CDMO Revenue Market Share by Type (2020-2025)
Table 27. Global CGT CDMO Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 28. Global CGT CDMO Revenue Market Share by Type (2026-2031)
Table 29. Global CGT CDMO Market Size by Application (2020-2025) & (US$ Million)
Table 30. Global CGT CDMO Revenue Market Share by Application (2020-2025)
Table 31. Global CGT CDMO Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 32. Global CGT CDMO Revenue Market Share by Application (2026-2031)
Table 33. North America CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 34. North America CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 35. North America CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 36. Europe CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 37. Europe CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 38. Europe CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 39. Asia-Pacific CGT CDMO Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 40. Asia-Pacific CGT CDMO Market Size by Region (2020-2025) & (US$ Million)
Table 41. Asia-Pacific CGT CDMO Market Size by Region (2026-2031) & (US$ Million)
Table 42. Latin America CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 43. Latin America CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 44. Latin America CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 45. Middle East & Africa CGT CDMO Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 46. Middle East & Africa CGT CDMO Market Size by Country (2020-2025) & (US$ Million)
Table 47. Middle East & Africa CGT CDMO Market Size by Country (2026-2031) & (US$ Million)
Table 48. Catalent Company Details
Table 49. Catalent Business Overview
Table 50. Catalent CGT CDMO Product
Table 51. Catalent Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 52. Catalent Recent Development
Table 53. Lonza Company Details
Table 54. Lonza Business Overview
Table 55. Lonza CGT CDMO Product
Table 56. Lonza Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 57. Lonza Recent Development
Table 58. Thermo Fisher Company Details
Table 59. Thermo Fisher Business Overview
Table 60. Thermo Fisher CGT CDMO Product
Table 61. Thermo Fisher Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 62. Thermo Fisher Recent Development
Table 63. ACG Biologics Company Details
Table 64. ACG Biologics Business Overview
Table 65. ACG Biologics CGT CDMO Product
Table 66. ACG Biologics Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 67. ACG Biologics Recent Development
Table 68. WuXi AppTec Company Details
Table 69. WuXi AppTec Business Overview
Table 70. WuXi AppTec CGT CDMO Product
Table 71. WuXi AppTec Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 72. WuXi AppTec Recent Development
Table 73. Charles River Company Details
Table 74. Charles River Business Overview
Table 75. Charles River CGT CDMO Product
Table 76. Charles River Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 77. Charles River Recent Development
Table 78. Oxford Biomedica (OXB) Company Details
Table 79. Oxford Biomedica (OXB) Business Overview
Table 80. Oxford Biomedica (OXB) CGT CDMO Product
Table 81. Oxford Biomedica (OXB) Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 82. Oxford Biomedica (OXB) Recent Development
Table 83. Novartis Company Details
Table 84. Novartis Business Overview
Table 85. Novartis CGT CDMO Product
Table 86. Novartis Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 87. Novartis Recent Development
Table 88. OBiO Company Details
Table 89. OBiO Business Overview
Table 90. OBiO CGT CDMO Product
Table 91. OBiO Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 92. OBiO Recent Development
Table 93. GenScript Company Details
Table 94. GenScript Business Overview
Table 95. GenScript CGT CDMO Product
Table 96. GenScript Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 97. GenScript Recent Development
Table 98. Pharmaron Company Details
Table 99. Pharmaron Business Overview
Table 100. Pharmaron CGT CDMO Product
Table 101. Pharmaron Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 102. Pharmaron Recent Development
Table 103. Porton Company Details
Table 104. Porton Business Overview
Table 105. Porton CGT CDMO Product
Table 106. Porton Revenue in CGT CDMO Business (2020-2025) & (US$ Million)
Table 107. Porton Recent Development
Table 108. Research Programs/Design for This Report
Table 109. Key Data Information from Secondary Sources
Table 110. Key Data Information from Primary Sources
Table 111. Authors List of This Report
List of Figures
Figure 1. CGT CDMO Picture
Figure 2. Global CGT CDMO Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global CGT CDMO Market Share by Type: 2024 VS 2031
Figure 4. Immune Cells Features
Figure 5. Stem Cells Features
Figure 6. Viral Vectors Features
Figure 7. Plasmid DNA Features
Figure 8. Global CGT CDMO Market Size by Application (2020-2031) & (US$ Million)
Figure 9. Global CGT CDMO Market Share by Application: 2024 VS 2031
Figure 10. Pharmaceutical and Biotechnology Companies Case Studies
Figure 11. Research and Academic Institutions Case Studies
Figure 12. Hospital Case Studies
Figure 13. Others Case Studies
Figure 14. CGT CDMO Report Years Considered
Figure 15. Global CGT CDMO Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global CGT CDMO Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global CGT CDMO Market Share by Region: 2024 VS 2031
Figure 18. Global CGT CDMO Market Share by Players in 2024
Figure 19. Global Top CGT CDMO Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in CGT CDMO as of 2024)
Figure 20. The Top 10 and 5 Players Market Share by CGT CDMO Revenue in 2024
Figure 21. North America CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America CGT CDMO Market Share by Country (2020-2031)
Figure 23. United States CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe CGT CDMO Market Share by Country (2020-2031)
Figure 27. Germany CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Nordic Countries CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific CGT CDMO Market Share by Region (2020-2031)
Figure 35. China CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America CGT CDMO Market Share by Country (2020-2031)
Figure 43. Mexico CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa CGT CDMO Market Share by Country (2020-2031)
Figure 47. Turkey CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE CGT CDMO Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. Catalent Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 51. Lonza Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 52. Thermo Fisher Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 53. ACG Biologics Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 54. WuXi AppTec Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 55. Charles River Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 56. Oxford Biomedica (OXB) Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 57. Novartis Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 58. OBiO Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 59. GenScript Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 60. Pharmaron Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 61. Porton Revenue Growth Rate in CGT CDMO Business (2020-2025)
Figure 62. Bottom-up and Top-down Approaches for This Report
Figure 63. Data Triangulation
Figure 64. Key Executives Interviewed
Our team would be happy to assist you with your queries.
About us
Accurate data, The latest market trends, And deeper research directions.
Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals
Latest reports
Global Oral Antianginal Drugs Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Polyester BCF Yarns Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Global Glass Mat Reinforced Thermoplastics (GMT) for Automotive Market Outlook, In‑Depth Analysis & Forecast to 2031
Oct 21, 25
Useful links
Our Contacts
Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China
(+86) 159 1069 5232